Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.
$24.72M
Mr. Peter L. Hoang MBA
56.00
Houston, TX
Nov 08, 2016
-2.41
$-1.15
3.96
5.92
-276.53%
-2.41
-0.04
2.56
6.68
5.92
-88.29%
-78.91%
Similar stocks (16)
Keros Therapeutics, Inc.
KROS
Edgewise Therapeutics, Inc.
EWTX
Alector, Inc.
ALEC
Acrivon Therapeutics, Inc. Common Stock
ACRV
Agenus Inc.
AGEN
Ikena Oncology, Inc.
IKNA
PMV Pharmaceuticals, Inc.
PMVP
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
Aadi Bioscience, Inc.
AADI
Tempest Therapeutics, Inc.
TPST
Lumos Pharma, Inc.
LUMO
RenovoRx, Inc.
RNXT
Galera Therapeutics, Inc.
GRTX
Exicure, Inc.
XCUR
Protagenic Therapeutics, Inc.
PTIX
ETF Exposure (7)
iShares Micro-Cap ETF
IWC
0.00603%
Dimensional U.S. Small Cap ETF
DFAS
1.6262e-4%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (16)
Keros Therapeutics, Inc.
KROS
Edgewise Therapeutics, Inc.
EWTX
Alector, Inc.
ALEC
Acrivon Therapeutics, Inc. Common Stock
ACRV
Agenus Inc.
AGEN
Ikena Oncology, Inc.
IKNA
PMV Pharmaceuticals, Inc.
PMVP
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
Aadi Bioscience, Inc.
AADI
Tempest Therapeutics, Inc.
TPST
Lumos Pharma, Inc.
LUMO
RenovoRx, Inc.
RNXT
Galera Therapeutics, Inc.
GRTX
Exicure, Inc.
XCUR
Protagenic Therapeutics, Inc.
PTIX
ETF Exposure (7)
iShares Micro-Cap ETF
IWC
0.00603%
Dimensional U.S. Small Cap ETF
DFAS
1.6262e-4%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%